site map
  • 이미지

Home > 메나리니 소식 > 메나리니 뉴스

메나리니 뉴스

  • 확대
  • 축소

  The 17,000th employee of the Menarini Group is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed at Menarini Ricerche.

  Menarini is present in 136 countries world-wide and continues to invest heavily in Italy: out of
17,000 Group employees, more than 3,700 work in Italy, almost 300 of whom hired over the last
two years and work in the Group’s Florentine headquarters.

  With an average age of 29, more than 90% of Menarini employees hold a degree or a technical
diploma and cover highly qualified profiles.

  "We are proud of this achievement - said Lucia Aleotti and Alberto Giovanni Aleotti, Chairman and Vice Chairman of the Menarini Group - and take this opportunity to highlight how being able to hire the 17,000th staff member is largely due to the extraordinary work carried out by all our employees who, with enthusiasm and determination, are the true makers of the success of the Menarini Group."

  With the opening of two new affiliates in Peru and Colombia, investments in the Berlin and Pisa
research centers, and the growth of Asia Pacific, Menarini's strategy has always been focused on
both the quality of their products and internationalization. Menarini closed the year 2017 with a urnover of 3.6 billion Euro.

  About the Menarini Group
  The Menarini Group is an Italian pharmaceutical company, 12th in Europe out of 5,255 companies, and 36th company in the world out of 20,862 companies, with a turnover of more than 3,5 billion Euro and more than 16,700 employees. The Menarini Group has always pursued two strategic objectives: Research and Internationalisation and is present in the most important therapeutic areas including products for cardiology, gastroenterology, pneumology/antibiotics, diabetology, anti-inflammatory agents/analgesics. With 16 production sites and 6 Research and Development centers, the Menarini Group has a strong presence throughout Europe and Asia, Africa, Central and South America. Menarini’s products are available in 136 countries worldwide. For further information please visit

메나리니 뉴스
Menarini 그룹과 Radius Health, 글로벌 라이선스 계약 07 2020
손발톱무좀약 시장 요동...풀케어, 여름 앞두고 반격채비 07 2020
한국메나리니 BENEFIT 연구 결과 발표 기사 사진 01 2020
메나리니, 한국 등 68개국서 3개 항생제 발매권 10 2018
더마틱스 울트라, 새 광고모델 배우 조정석 발탁 04 2017
더마틱스 울트라, 2016 대한민국 제약산업 광고홍보대상 프러덕트 부문 12 2016
풀케어, 매경 광고대상 뉴미디어부문 우수상 수상 12 2016
더마틱스 울트라, 한국PR대상 마케팅PR부문 최우수상 수상 12 2016
더마틱스 울트라, 2016 중앙일보 소비자의 선택 흉터개선제 부문 대상 12 2016
OTC 학술자료, 약사님들이 먼저 요구 10 2016
메나리니, ‘세계고혈압학회 서울 2016’ 참가 09 2016
메나리니, 심장병어린이 수술비 300여만원 후원 05 2016
흉터치료제, 꼼꼼히 따져보면 '정답' 보인다 05 2016
보도자료 - 한국메나리니 발기부전 치료제 고든 구강용해필름 출시 첨부파일 09 2015
한국메나리니, 한국심장재단에 기부금 전달 - 메디게이트 뉴스 05 2015
한국메나리니, 한국심장재단에 캠페인 기부금 전달 - 연합뉴스 05 2015
메나리니 AP, 獨 제약사와 항암제 판매계약 05 2015
메나리니 AP, 4SC AG와 계약 체결 05 2015
메나리니 AP, 항암제 '레스미노스타트' 국내 판권 확보 05 2015
처음페이지이전 10 페이지12다음 10 페이지마지막페이지
  • 블랙라인
  • Aside Information
  • 질병관련 뉴스
  • 년간 주요행사
  • 공지사항
  • 레드라인
  • Featured Article
  • 블랙라인
  • Featured Brands
    • priligy
    • nebilet
    • fulcare
    • dermatix
    • godn